PHARMACEUTICAL DRY POWDER COMPOSITION AND METHODS FOR TREATING RESPIRATORY TRACT INFECTIONS
Applicants:
- LIITA CARE APS
Abstract
The present invention provides a pharmaceutical dry powder composition for use in treating, preventing and/or ameliorating viral infection in airways of a mammal, such as a human subject, said composition comprising micronized sodium salt as the main component and primary therapeutic agent. The present invention further provides a pharmaceutical composition for use in treating and/or ameliorating cough. The subject to be treated with the pharmaceutical composition may be infected with SARS-CoV-2 and/or diagnosed with COVID-19 infection. The pharmaceutical composition is administered by dry powder inhalation.
Patent Family Records (1)
PHARMACEUTICAL DRY POWDER COMPOSITION AND METHODS FOR TREATING RESPIRATORY TRACT INFECTIONS
LIITA CARE APS MINAMOTO SUZANA ERICO TANNI, OHRT MARTIN
2024, WO-2024046582-A1